subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: Advanced Follicular Lymphoma

tested_intervention: unsure


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Cutaneous Lichen Planus


subject: UMLS:C4045875


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: alcoholic liver cirrhosis


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UNII:2F25P9Y22O

object_name: Alzheimer disease


subject: UMLS:C4305903


subject: CHEBI:33324

subject_name: strontium atom

object_name: open-angle glaucoma


subject: CHEBI:33324

object_name: ocular hypertension


subject: CHEBI:33324

object_name: Ocular hypertension


subject: CHEBI:4911

subject_name: Etoposide

object_name: fallopian tube neoplasm


subject: CHEBI:4911

object_name: peritoneal neoplasm


subject: CHEBI:4911

object_name: esophageal squamous cell carcinoma


subject: CHEBI:4911

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410

object_name: small cell lung carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961

object_name: ovarian cancer


subject: CHEBI:80961

object_name: ovarian neoplasm


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:80961


subject: CHEBI:80961

object_name: gastric neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:3139

subject_name: bleomycin

object_name: vulval Paget disease

tested_intervention: yes


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: UNII:M89N0Q7EQR

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: UNII:M89N0Q7EQR

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UNII:M89N0Q7EQR

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:M89N0Q7EQR

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:M89N0Q7EQR

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:M89N0Q7EQR

object_name: Cutaneous T-cell lymphoma stage II


subject: UNII:M89N0Q7EQR

object_name: Cutaneous T-cell lymphoma stage I


subject: UNII:M89N0Q7EQR

object_name: Cutaneous T-cell lymphoma stage IV


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: CHEBI:9150

subject_name: Simvastatin

object_name: skeletal muscle disorder


subject: UNII:9J765S329G

subject_name: L-Thyroxine sodium salt pentahydrate

object_name: schizophrenia


subject: CHEBI:6447

subject_name: levothyroxine sodium hydrate


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UMLS:C0079691

subject_name: Levothroid


subject: CHEBI:31485

subject_name: Difluprednate

object_name: Cataract, CTCAE 3.0


subject: CHEBI:31485

object_name: Cataract, CTCAE 5.0


subject: CHEBI:31485

object_name: cataract on exam (physical finding)


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: dementia pugilistica


subject: CHEBI:7773

subject_name: Ondansetron

object_name: traumatic encephalopathy


subject: CHEBI:7773

object_name: traumatic brain injury


subject: CHEBI:7773

object_name: concussion


subject: UNII:OKA0O253JZ

subject_name: LUFEPIRSEN

object_name: Persistent corneal epithelial defect


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Acute Ischemic Stroke


subject: MESH:D000077203

object_name: Ischemic stroke


subject: CHEBI:6121

subject_name: Ketamine

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: neoplasm


subject: CHEBI:7986

object_name: Tumor Mass


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:142406

subject_name: ziconotide

object_name: neuropathy, painful


subject: PUBCHEM.COMPOUND:16135415

subject_name: Ziconotide


subject: UMLS:C1328138

object_name: mycosis fungoides


subject: UMLS:C1328138

object_name: Sezary syndrome


subject: UNII:HG3L8885M0

subject_name: zanolimumab


subject: UNII:HG3L8885M0


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: anemia deficiency iron treatment


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: UMLS:C5706467

subject_name: Manganese-based Contrast Agent RVP-001

object_name: Central nervous system lesion


subject: UMLS:C5706467

object_name: multiple sclerosis


subject: UMLS:C5706467

object_name: brain neoplasm


subject: UMLS:C5706467

object_name: Multiple sclerosis brain lesion


subject: UMLS:C5706467

object_name: Recurrent Brain Neoplasm


subject: UMLS:C5706467

object_name: central nervous system neoplasm


subject: UMLS:C5706467

object_name: central nervous system cancer


subject: UMLS:C5706467

object_name: primary brain neoplasm


subject: UMLS:C5706467

object_name: brain cancer


subject: UMLS:C5706467

object_name: benign neoplasm of brain


subject: UMLS:C5706467

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5706467

object_name: primary central nervous system lymphoma


subject: UMLS:C5706467

object_name: Malignant neoplasm of the central nervous system


subject: UMLS:C5706467

object_name: neuronitis


subject: UMLS:C5706467

object_name: Neuroinflammation


subject: UMLS:C5706467

object_name: CNS metastases


subject: UMLS:C5706467

object_name: acoustic neuroma


subject: UMLS:C5706467

object_name: neoplastic syndrome


subject: UMLS:C5706467

object_name: neoplasm


subject: UMLS:C5706467

object_name: neurofibroma


subject: UMLS:C5706467

object_name: schwannoma


subject: UMLS:C5706467

object_name: Adult Meningioma


subject: UMLS:C5706467

object_name: benign meningioma


subject: UMLS:C5706467

object_name: familial meningioma


subject: UMLS:C5706467

object_name: pediatric meningioma


subject: UMLS:C5706467

object_name: meningioma


subject: UMLS:C5706467

object_name: glioma


subject: UMLS:C5706467

object_name: malignant glioma


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: Chronic small plaque psoriasis


subject: CHEBI:31687

subject_name: Idebenone

object_name: migraine


subject: CHEBI:31687

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:C3ZUM5A33F

object_name: ovarian cancer


subject: UNII:C3ZUM5A33F

object_name: ovarian neoplasm


subject: UNII:C3ZUM5A33F

object_name: Childhood Breast Carcinoma


subject: UNII:C3ZUM5A33F

object_name: breast carcinoma


subject: UNII:C3ZUM5A33F

object_name: breast cancer


subject: UNII:C3ZUM5A33F

object_name: Stomach cancer


subject: UNII:C3ZUM5A33F

object_name: gastric cancer


subject: UNII:C3ZUM5A33F

object_name: cervical cancer


subject: UNII:C3ZUM5A33F

object_name: cervical carcinoma


subject: UNII:C3ZUM5A33F

object_name: endometrial cancer


subject: UNII:C3ZUM5A33F

object_name: uterine corpus cancer


subject: UNII:C3ZUM5A33F

object_name: endometrial carcinoma


subject: UNII:C3ZUM5A33F

object_name: Neck Carcinoma


subject: UNII:C3ZUM5A33F

object_name: head and neck neoplasm


subject: UNII:C3ZUM5A33F

object_name: head and neck cancer


subject: UNII:C3ZUM5A33F

object_name: colorectal cancer


subject: UNII:C3ZUM5A33F

object_name: colorectal carcinoma


subject: UNII:C3ZUM5A33F

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:C3ZUM5A33F

object_name: carcinoma of esophagus


subject: UNII:C3ZUM5A33F

object_name: esophageal cancer


subject: UNII:C3ZUM5A33F

object_name: Childhood Esophageal Carcinoma


subject: UNII:C3ZUM5A33F

object_name: neoplasm of esophagus


subject: UNII:C3ZUM5A33F

object_name: thyroid gland papillary carcinoma


subject: UNII:C3ZUM5A33F

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:C3ZUM5A33F

object_name: malignant peritoneal mesothelioma


subject: UNII:C3ZUM5A33F

object_name: malignant pleural mesothelioma


subject: UNII:C3ZUM5A33F

object_name: malignant glioma


subject: UNII:C3ZUM5A33F

object_name: diffuse intrinsic pontine glioma


subject: UNII:C3ZUM5A33F

object_name: melanoma


subject: UNII:C3ZUM5A33F

object_name: non-small cell lung carcinoma


subject: CHEBI:41948

subject_name: Eflornithine

object_name: ovarian cancer


subject: CHEBI:41948

object_name: ovarian neoplasm


subject: CHEBI:41948

object_name: Childhood Breast Carcinoma


subject: CHEBI:41948

object_name: breast carcinoma


subject: CHEBI:41948

object_name: breast cancer


subject: CHEBI:41948

object_name: endometrial cancer


subject: CHEBI:41948

object_name: uterine corpus cancer


subject: CHEBI:41948

object_name: endometrial carcinoma


subject: CHEBI:41948

object_name: Neck Carcinoma


subject: CHEBI:41948

object_name: head and neck neoplasm


subject: CHEBI:41948

object_name: head and neck cancer


subject: CHEBI:41948

object_name: thyroid gland papillary carcinoma


subject: CHEBI:41948

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:41948

object_name: malignant peritoneal mesothelioma


subject: CHEBI:41948

object_name: malignant pleural mesothelioma


subject: CHEBI:41948

object_name: malignant glioma


subject: CHEBI:41948

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:41948

object_name: melanoma


subject: CHEBI:41948

object_name: non-small cell lung carcinoma


subject: CHEBI:74707

subject_name: Met-Met

object_name: monoclonal gammopathy of uncertain significance


subject: CHEBI:53458


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: Episodic migraine


subject: UNII:997WVV895X

object_name: Photophobia, CTCAE 5.0


subject: UNII:997WVV895X

object_name: Photophobia


subject: UNII:997WVV895X

object_name: hyperacusis


subject: UNII:997WVV895X

object_name: Phonophobia


subject: RXCUI:284756

subject_name: Kaletra

object_name: HIV-1 infection


subject: CHEBI:8107

subject_name: Phenytoin

object_name: asthma


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Stevens-Johnson syndrome


subject: CHEBI:71200

object_name: Stevens-Johnson Syndrome, CTCAE


subject: UMLS:C3248666

subject_name: Injection, belimumab, 10 mg administered

object_name: EXCESS LMW-DNA


subject: UMLS:C5203380

subject_name: Belimumab Liquid Injection


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: Metastatic non-small cell lung cancer


subject: PR:000001151

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:231369

subject_name: Savolitinib

object_name: gastric adenocarcinoma


subject: CHEBI:5959

subject_name: Irbesartan

object_name: congestive heart failure


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Perioperative complication


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:9332

subject_name: Sulfamethoxazole

object_name: Recurrent urinary tract infections


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: tonsillitis


subject: CHEBI:41879

object_name: Obstructive sleep apnea of child


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: craniopharyngioma


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:28918

subject_name: Epinephrine

object_name: intervertebral disk degenerative disorder


subject: CHEBI:28918

object_name: lumbar disk degenerative disorder


subject: CHEBI:28918

object_name: lumbar disc herniation


subject: CHEBI:28918

object_name: spondylolisthesis


subject: CHEBI:28918

object_name: Congenital spondylolisthesis


subject: CHEBI:28918

object_name: Acquired spondylolisthesis


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:34954

subject_name: (S)-ropivacaine hydrochloride hydrate


subject: CHEBI:34954


subject: CHEBI:34954


subject: CHEBI:34954


subject: CHEBI:34954


subject: CHEBI:34954


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:6931

subject_name: Midazolam

object_name: postmenopausal osteoporosis


subject: CHEMBL.COMPOUND:CHEMBL55643

subject_name: COPPER


subject: CHEBI:28694

subject_name: Copper


subject: CHEBI:29036

subject_name: Cupric cation


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Recurrent Malignant Glioma


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:174690

subject_name: Clenbuterol

object_name: Pompe's disease adult onset


subject: CHEBI:174690

object_name: glycogen storage disease due to acid maltase deficiency, late-onset


subject: UMLS:C5882237

subject_name: AMG 570

object_name: EXCESS LMW-DNA


subject: UMLS:C2984523

object_name: neoplasm


subject: CHEBI:27470

subject_name: Folic acid

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:27470

object_name: Hodgkin Disease


subject: CHEBI:27470

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5203275

subject_name: Pralatrexate Liquid Injection


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C5203275

object_name: B-cell neoplasm


subject: UMLS:C2959279

subject_name: Injection, pralatrexate, 1 mg


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:71223


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: persistent fetal circulation syndrome


subject: CHEBI:31300

object_name: alveolar capillary dysplasia with misalignment of pulmonary veins


subject: CHEBI:31300

object_name: Persistent Pulmonary Hypertension of the Newborn, AE


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:91327

subject_name: Tivozanib

object_name: primary peritoneal carcinoma


subject: CHEBI:91327

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:91327

object_name: peritoneal carcinoma


subject: CHEBI:91327

object_name: fallopian tube carcinoma


subject: CHEBI:91327

object_name: fallopian tube cancer


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Mechanical ventilation finding


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: UMLS:C0018061

subject_name: Gonadotropins

object_name: ovarian hyperstimulation syndrome


subject: UMLS:C3536870

subject_name: Gonadotropin [EPC]


subject: CHEBI:6904

subject_name: Metoprolol

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:6904

object_name: metabolic syndrome X


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:64019


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: indolent B-cell non-Hodgkin lymphoma


subject: UNII:LDJ89SS0YG

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) recurrent


subject: UNII:LDJ89SS0YG

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) refractory


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UNII:KG6VO684Z6

object_name: grade 3A follicular lymphoma


subject: UNII:KG6VO684Z6

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UNII:KG6VO684Z6

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3898446

subject_name: Mechlorethamine Hydrochloride Gel

object_name: mycosis fungoides


subject: UMLS:C4744839

subject_name: Pharmacological Ascorbate

object_name: non-small cell lung carcinoma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: type 1 diabetes mellitus 1


subject: UNII:I031V2H011

object_name: type 1 diabetes mellitus


subject: CHEBI:15367

subject_name: Tretinoin

object_name: hypopharynx cancer


subject: CHEBI:15367

object_name: oropharyngeal carcinoma


subject: CHEBI:15367

object_name: oropharynx cancer


subject: CHEBI:15367

object_name: laryngeal carcinoma


subject: CHEBI:15367

object_name: larynx cancer


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:83766

subject_name: Olaparib

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: Refractory drug response


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:231679

subject_name: ipilimumab

object_name: small cell carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:177413

subject_name: Plinabulin

object_name: lung cancer


subject: CHEBI:177413

object_name: lung neoplasm


subject: CHEBI:177413

object_name: lung carcinoma


subject: CHEBI:177413


subject: CHEBI:177413

object_name: small cell lung carcinoma


subject: UMLS:C1741609


subject: UMLS:C1741609


subject: UMLS:C1741609


subject: UMLS:C1741609


subject: UMLS:C1741609


subject: MESH:C000730795

object_name: Hypoproteinemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: CHEBI:4026

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:4026

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:4026

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:4026

object_name: Squamous cell carcinoma of the oral cavity stage II


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:ZDR4QSJ43F


subject: UNII:ZDR4QSJ43F


subject: UNII:ZDR4QSJ43F


subject: UNII:ZDR4QSJ43F


subject: UNII:ZDR4QSJ43F


subject: UMLS:C0758290

subject_name: IRX 2


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: UMLS:C0758290


subject: CHEBI:231614


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:5245480

object_name: non-small cell lung carcinoma


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic urothelial carcinoma


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: GTOPDB:12349

subject_name: zimberelimab


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: CHEBI:60799

subject_name: Esketamine

object_name: Consent Type - Hysterectomy


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Intraocular inflammation


subject: UMLS:C4726002

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:91451

object_name: metastatic melanoma


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: type 1 diabetes mellitus 1


subject: CHEBI:167450

object_name: type 1 diabetes mellitus


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: CHEBI:45783

subject_name: Imatinib

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:7465

subject_name: Naltrexone

object_name: substance-related disorder


subject: CHEBI:23965

subject_name: estradiol

object_name: Fecal Incontinence, CTCAE


subject: CHEBI:149504

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:149504

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: CHEBI:149504

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Parkinson disease


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C1710381

subject_name: Circadin

object_name: insomnia


subject: UMLS:C1710381

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C1710381

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C1710381

object_name: type 2 diabetes mellitus


subject: CHEBI:231490

subject_name: cyclo(L-arginyl-L-glutamyl) zwitterion

object_name: sarcopenia


subject: CHEBI:38940

subject_name: Sunitinib

object_name: gliosarcoma


subject: CHEBI:38940

object_name: Childhood Gliosarcoma


subject: CHEBI:38940

object_name: central nervous system sarcoma


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Activating MET Gene Mutation


subject: CHEBI:64310

subject_name: Crizotinib


subject: UMLS:C2958902

subject_name: Injection, telavancin, 10 mg administered

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Morton neuroma


subject: CHEBI:31498

subject_name: Simethicone

object_name: dyspepsia


subject: CHEBI:31498

object_name: Dyspepsia, CTCAE


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Pediatric Disorder


subject: CHEBI:6970

subject_name: Mometasone

object_name: rhinitis


subject: PR:000034288

subject_name: N-acetylmuramoyl-L-alanine amidase AmiA

object_name: Safety Issues


subject: PUBCHEM.COMPOUND:21880659

subject_name: Vilanterol

object_name: non-small cell lung carcinoma


subject: CHEBI:79040

subject_name: umeclidinium bromide


subject: UNII:GE2T1418SV

subject_name: Umeclidinium


subject: CHEBI:195558

subject_name: Entrectinib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:195558

object_name: acute myeloid leukemia


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: Cardiovascular morbidity


subject: UMLS:C4033631

object_name: Left Ventricular Diastolic Dysfunction, CTCAE


subject: UMLS:C4033631

object_name: Left ventricular diastolic dysfunction


subject: UMLS:C4033631

object_name: Atrial arrhythmia


subject: UMLS:C4033631

object_name: Myocardial fibrosis


subject: UMLS:C4033631

object_name: inclusion body myositis


subject: UMLS:C4033631

object_name: myositis


subject: UMLS:C4033631

object_name: Inflammatory myopathy


subject: UMLS:C0876768

subject_name: Vioxx

object_name: Stomach cancer


subject: UMLS:C0876768

object_name: gastric cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: kidney disorder


subject: CHEBI:4466

object_name: impaired renal function disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Low back pain


subject: UMLS:C0006055

object_name: Neck pain


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:66964

object_name: colon carcinoma


subject: CHEBI:66964

object_name: breast carcinoma


subject: CHEBI:9546

subject_name: Thimerosal

object_name: contact dermatitis


subject: UMLS:C5959224

subject_name: Anti-ENTPD2 Monoclonal Antibody KAZ954

object_name: Solid Neoplasm


subject: UMLS:C4764072


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Major depression with psychotic features


subject: PUBCHEM.COMPOUND:24205

subject_name: VITAMIN E QUINONE

object_name: Friedreich ataxia


subject: UNII:ZO763K43XR

subject_name: TOCOQUINONE


subject: CHEBI:28838

subject_name: Lutein

object_name: Osteopenia


subject: CHEBI:27547

subject_name: Zeaxanthin


subject: PR:000014156

subject_name: protein rogdi

object_name: age-related macular degeneration


subject: PR:000014156


subject: CHEBI:16302

object_name: HIV Seronegativity


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:15365

subject_name: Aspirin

object_name: Diabetes


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Obstructive sleep apnea of adult


subject: CHEBI:156287

subject_name: Pidnarulex

object_name: Burkitt lymphoma


subject: CHEBI:156287

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:156287

object_name: Adult Burkitt Lymphoma


subject: CHEBI:156287

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: CHEBI:156287

object_name: Double-Expressor Lymphoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Blood Pressure Finding


subject: CHEBI:39548

object_name: Systemic arterial pressure


subject: CHEBI:8024

subject_name: Perindopril

object_name: inherited lipid metabolism disorder


subject: UNII:F0B69ZZ07A

subject_name: EMPEGFILGRASTIM

object_name: Childhood Breast Carcinoma


subject: UNII:F0B69ZZ07A

object_name: breast carcinoma


subject: UNII:F0B69ZZ07A

object_name: breast cancer


subject: UNII:F0B69ZZ07A

object_name: digestive system cancer


subject: UNII:F0B69ZZ07A

object_name: High-Risk Cancer


subject: UNII:F0B69ZZ07A

object_name: myelosuppression


subject: UNII:F0B69ZZ07A

object_name: Childhood Solid Neoplasm


subject: UNII:F0B69ZZ07A

object_name: Adult Solid Neoplasm


subject: UNII:F0B69ZZ07A

object_name: Solid Neoplasm


subject: UMLS:C4301614

subject_name: Empegfilgrastim


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C4301614


subject: UMLS:C0795577

subject_name: recombinant antihemophilic factor VIII

object_name: hemophilia


subject: CHEBI:138655

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PR:000015485

subject_name: spermatogenesis-associated protein 2


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UNII:84I5UEP321

object_name: non-small cell lung carcinoma


subject: UMLS:C4053608

subject_name: A2AR Antagonist PBF-509


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: adolescent idiopathic scoliosis


subject: CHEBI:94518

object_name: scoliosis, isolated, susceptibility to, 1


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Vomiting, Postoperative


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: transitional cell carcinoma


subject: CHEBI:63605

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:63605

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:63605

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:63605

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:63605

object_name: Bladder cancer recurrent


subject: CHEBI:63605

object_name: Recurrent Urethral Cancer


subject: CHEBI:63605

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:63605

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:63605

object_name: Distal Urethral Carcinoma


subject: CHEBI:63605

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:63605

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:63605

object_name: Bladder cancer stage IV


subject: CHEBI:63605

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:63605

object_name: posterior urethra cancer


subject: CHEBI:63605

object_name: Proximal Urethral Carcinoma


subject: UMLS:C2981231

subject_name: fulranumab

object_name: Splitting Pain


subject: UMLS:C2981231

object_name: Burning Pain


subject: UMLS:C2981231

object_name: Pain, Migratory


subject: UMLS:C2981231

object_name: Radiating pain


subject: UMLS:C2981231

object_name: Crushing Pain


subject: CHEBI:10023

subject_name: Voriconazole


subject: CHEBI:10023

object_name: Childhood Neuroblastoma


subject: CHEBI:10023

object_name: neuroblastoma


subject: CHEBI:10023

object_name: renal carcinoma


subject: CHEBI:10023

object_name: kidney neoplasm


subject: CHEBI:10023

object_name: kidney cancer


subject: CHEBI:10023

object_name: malignant soft tissue neoplasm


subject: CHEBI:10023

object_name: sarcoma


subject: UMLS:C4552073

subject_name: Calcium Aluminosilicate Anti-Diarrheal

object_name: Clostridium difficile diarrhea


subject: UNII:6897GXD6OE

object_name: colon carcinoma


subject: UNII:6897GXD6OE

object_name: colorectal cancer


subject: UNII:6897GXD6OE

object_name: colon cancer


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Human Papillomavirus-16 Positive


subject: UMLS:C2703096

object_name: Human Papillomavirus-18 Positive


subject: UMLS:C2703096


subject: UMLS:C2703096

object_name: Anal intraepithelial neoplasia


subject: UMLS:C2703096

object_name: Human Immunodeficiency Virus Positive


subject: UMLS:C2984527

subject_name: DLBS 1425

object_name: Childhood Breast Carcinoma


subject: UMLS:C2984527

object_name: breast carcinoma


subject: UMLS:C2984527

object_name: breast cancer


subject: UMLS:C0036080

subject_name: Salicylic Acids

object_name: acne


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: stage IVA rectal cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVA Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVB Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135423438

object_name: stage IVB rectal cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: stage IVB colon cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVB Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135423438

object_name: stage IVA colon cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVA Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IVA Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135423438

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:135423438

object_name: colon adenocarcinoma


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: UMLS:C3661192

object_name: Childhood Solid Neoplasm


subject: UMLS:C3661192

object_name: Adult Solid Neoplasm


subject: UMLS:C3661192

object_name: Solid Neoplasm


subject: CHEBI:68575

subject_name: Indacaterol

object_name: Persistent asthma


subject: CHEBI:7514

subject_name: Neostigmine

object_name: cirrhosis and chronic liver disease


subject: CHEBI:8884

subject_name: Rocuronium


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:131182

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:131182

object_name: ovarian neoplasm


subject: MESH:C000720852

object_name: precursor B-cell acute lymphoblastic leukemia


subject: MESH:C000720852

object_name: B-cell childhood acute lymphoblastic leukemia


subject: MESH:C000720852

object_name: B-cell adult acute lymphocytic leukemia


subject: MESH:C000720852

object_name: B-cell acute lymphoblastic leukemia


subject: MESH:C000720852

object_name: CD19 Positive


subject: MESH:C000720852

object_name: Philadelphia Chromosome Positive


subject: MESH:C000720852

object_name: Neoplasm, Residual


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Cervicogenic Headache


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C5777100

object_name: Alopecia, CTCAE


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: Diabetes


subject: UNII:N824AOU5XV

object_name: diabetes mellitus


subject: UNII:N824AOU5XV

object_name: abdominal obesity-metabolic syndrome


subject: UNII:N824AOU5XV

object_name: metabolic syndrome X


subject: CHEBI:17224

subject_name: Hymecromone

object_name: pulmonary hypertension


subject: CHEBI:17224

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:91899

object_name: melanoma


subject: CHEBI:3207

subject_name: Budesonide


subject: DRUGBANK:DB19013

subject_name: Insulin efsitora alfa

object_name: type 1 diabetes mellitus


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: lobular breast carcinoma in situ


subject: CHEBI:39548

object_name: ductal breast carcinoma in situ


subject: CHEBI:39548

object_name: atypical ductal hyperplasia


subject: UMLS:C0790233

subject_name: Distilled water

object_name: Cough


subject: UMLS:C0790233

object_name: Cough, CTCAE


subject: UMLS:C0790233

object_name: pharyngitis


subject: UMLS:C0790233

object_name: Pharyngalgia


subject: UMLS:C0790233

object_name: Sore Throat, CTCAE


subject: CHEBI:8499

subject_name: Propranolol

object_name: dystonia, focal, task-specific


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Pneumoperitoneum


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: prostate carcinoma


subject: UNII:420K487FSG

object_name: prostate cancer


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Neoplasm, Residual


subject: UMLS:C2983753

object_name: Childhood Glioblastoma


subject: UMLS:C2983753

object_name: adult glioblastoma


subject: CHEBI:149504

object_name: hyperglycemia


subject: CHEBI:149504

object_name: Hyperglycemia, CTCAE


subject: CHEBI:149504

object_name: Glucose in blood specimen above reference range


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: Irreversible pulpitis


subject: CHEBI:184472

object_name: Post-Operative Pain


subject: CHEBI:33283

subject_name: THIAMINE

object_name: dry beriberi


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: CHEBI:18385

subject_name: Thiamine


subject: UMLS:C4525309

object_name: Adult Solid Neoplasm


subject: UMLS:C4525309

object_name: Neck Carcinoma


subject: UMLS:C4525309

object_name: head and neck neoplasm


subject: UMLS:C4525309

object_name: head and neck cancer


subject: UMLS:C4525309

object_name: non-small cell lung carcinoma


subject: UMLS:C4525309

object_name: ovarian cancer


subject: UMLS:C4525309

object_name: ovarian neoplasm


subject: UMLS:C4525309

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:20802597

subject_name: Sapacitabine

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:20802597

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:20802597

object_name: breast cancer


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: Myelodysplasia, CTCAE


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: male infertility


subject: CHEBI:31527

object_name: Drug action (disorder)


subject: CHEBI:16899

subject_name: Mannitol

object_name: Exacerbation


subject: CHEBI:16899

object_name: COPD, severe early onset


subject: CHEBI:16899

object_name: chronic obstructive pulmonary disease


subject: CHEBI:135901

subject_name: lanreotide

object_name: digestive system neoplasm


subject: CHEBI:135901

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:135901

object_name: carcinoid tumor


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: UMLS:C4743011

object_name: inflammatory bowel disease


subject: CHEBI:7627

subject_name: Norethisterone

object_name: EXCESS LMW-DNA


subject: CHEBI:7627


subject: CHEBI:7627

object_name: psoriatic arthritis


subject: CHEBI:7627

object_name: psoriasis


subject: UNII:LVB74L4PM2

subject_name: SPEVATAMIG

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5783506


subject: CHEBI:66903

subject_name: Vismodegib

object_name: gastric neoplasm


subject: UNII:8V9YR09EF3

subject_name: Pinometostat

object_name: acute myeloid leukemia by FAB classification


subject: UNII:8V9YR09EF3

object_name: acute myeloid leukemia


subject: UMLS:C3827103

object_name: leukemia


subject: UMLS:C3827103

object_name: childhood leukemia


subject: UMLS:C0013162

subject_name: Drug Combinations

object_name: Recurrent Rectal Cancer


subject: UNII:634U7OUR4R

object_name: coronary artery disorder


subject: UNII:634U7OUR4R

object_name: coronary atherosclerosis


subject: UNII:634U7OUR4R

object_name: Diabetes


subject: UNII:634U7OUR4R

object_name: diabetes mellitus


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: autoimmune polyendocrinopathy


subject: UMLS:C0085826

object_name: antiphospholipid syndrome


subject: UMLS:C0085826

object_name: Major bleed


subject: UMLS:C0085826

object_name: transient ischemic attack


subject: UMLS:C0085826

object_name: cerebrovascular disorder


subject: UMLS:C5787295

subject_name: ACR 368

object_name: endometrium adenocarcinoma


subject: CHEBI:9123

subject_name: Sertraline

object_name: Heart Failure, CTCAE


subject: CHEBI:3374

subject_name: Capsaicin

object_name: burning mouth syndrome


subject: CHEBI:80566

subject_name: Palifosfamide

object_name: cancer


subject: CHEBI:80566

object_name: neoplasm


subject: CHEBI:80566

object_name: Primary malignant neoplasm


subject: CHEBI:80566

object_name: ovarian cancer


subject: CHEBI:80566

object_name: ovarian neoplasm


subject: CHEBI:80566

object_name: ovarian carcinoma


subject: CHEBI:80566

object_name: malignant testicular germ cell tumor


subject: CHEBI:80566

object_name: neoplasm of testis


subject: CHEBI:80566

object_name: testicular cancer


subject: CHEBI:80566

object_name: small cell lung carcinoma


subject: CHEBI:80566

object_name: non-small cell lung carcinoma


subject: CHEBI:80566

object_name: pediatric osteosarcoma


subject: CHEBI:80566

object_name: Osteosarcoma


subject: CHEBI:80566

object_name: thymoma


subject: CHEBI:80566

object_name: thymus neoplasm


subject: UMLS:C2987344

subject_name: palifosfamide-tris


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: MESH:C000632580

subject_name: TheraCal

object_name: dentin caries


subject: PUBCHEM.COMPOUND:76641559

subject_name: Dorzagliatin

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Wheezing


subject: UNII:1C6V77QF41

object_name: Wheezing, CTCAE


subject: UNII:1C6V77QF41

object_name: Allergy


subject: UNII:1C6V77QF41

object_name: History of allergies


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C4745170

subject_name: Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901

object_name: Colon Neoplasm


subject: UMLS:C4745171

subject_name: mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:230598

subject_name: Aplindore

object_name: Restless legs


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Recurrent Carcinoma


subject: UMLS:C4053601


subject: UMLS:C5854376

subject_name: CBL-B Inhibitor HST-1011

object_name: Adult Solid Neoplasm


subject: UMLS:C5854376

object_name: refractory malignant neoplasm


subject: UMLS:C5854376


subject: UMLS:C4744981

subject_name: 5-FU Analog Prodrug NUC-3373

object_name: cancer


subject: UMLS:C4744981

object_name: neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: esophageal squamous cell carcinoma


subject: CHEBI:49603

subject_name: Lapatinib

object_name: colorectal neoplasm


subject: UNII:HB76GLG27V

subject_name: Paquinimod

object_name: EXCESS LMW-DNA


subject: UMLS:C3493243


subject: CHEBI:77260

subject_name: Omeprazole

object_name: tinea pedis


subject: CHEBI:77260

object_name: tinea cruris


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Accelerated Phase of Disease


subject: CHEBI:201431

object_name: Chronic Phase of Disease


subject: CHEBI:201431

object_name: Recurrent disease


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: CHEBI:37598

subject_name: nitrogen mustard

object_name: mycosis fungoides


subject: UMLS:C0962969

subject_name: RAD 001

object_name: systemic mastocytosis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:544190

object_name: Drug Interactions


subject: CHEBI:7798

subject_name: Oseltamivir


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: Inflammatory Response


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: UMLS:C5704062

subject_name: Venlafaxine ER

object_name: social phobia


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: sleep apnea


subject: CHEBI:5801

object_name: Sleep Apnea, CTCAE


subject: CHEBI:5801

object_name: coronary microvascular disorder


subject: CHEBI:5801

object_name: coronary artery disorder


subject: CHEBI:5801

object_name: coronary atherosclerosis


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: refractory malignant neoplasm


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: PUBCHEM.COMPOUND:10820564

subject_name: Fluciclovine


subject: UMLS:C4310336

subject_name: Axumin


subject: CHEBI:134703

subject_name: Fluciclovine (18F)


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:46874763

object_name: Stenotrophomonas infection


subject: UMLS:C0003232

subject_name: Antibiotics


subject: PR:000013321

subject_name: testisin

object_name: asthma


subject: CHEBI:231681

subject_name: olaratumab

object_name: Embolism, Tumor


subject: CHEBI:231681

object_name: Metastasis


subject: CHEBI:231681

object_name: Metastatic Lesion


subject: CHEBI:231681

object_name: Primary malignant neoplasm


subject: CHEBI:231681

object_name: cancer


subject: CHEBI:94534

subject_name: olanzapine

object_name: hyperglycemia


subject: CHEBI:94534

object_name: Hyperglycemia, CTCAE


subject: CHEBI:94534

object_name: Glucose in blood specimen above reference range


subject: CHEBI:8707

subject_name: Quetiapine

object_name: type 2 diabetes mellitus


subject: CHEBI:8707


subject: CHEBI:8707


subject: CHEBI:8707


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: CHEBI:10119


subject: CHEBI:3374

subject_name: Capsaicin

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:3374

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:3374

object_name: pulmonary arterial hypertension


subject: UMLS:C1170120

subject_name: Caphosol


subject: UMLS:C1170120

object_name: neoplasm


subject: CHEBI:36080

subject_name: protein

object_name: Neck Carcinoma


subject: CHEBI:36080

object_name: head and neck cancer


subject: UMLS:C0033684

subject_name: Proteins


subject: UMLS:C0033684


subject: PR:000000001


subject: PR:000000001


subject: PR:000010424

subject_name: homeobox protein MIXL1


subject: PR:000010424

object_name: head and neck neoplasm


subject: PR:000010424


subject: PUBCHEM.COMPOUND:163362000

subject_name: ibuzatrelvir


subject: DRUGBANK:DB19451

subject_name: Ibuzatrelvir


subject: CHEBI:8028

subject_name: Perphenazine

object_name: schizoaffective disorder


subject: CHEBI:8028

object_name: schizophrenia 18


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: colorectal adenoma


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C2974550

object_name: liver cirrhosis


subject: UMLS:C4043370

subject_name: 3BNC117 antibody

object_name: AIDS


subject: CHEBI:3509


subject: CHEBI:161680

subject_name: Aztreonam


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: UMLS:C4331223

subject_name: Human Recombinant Bone Morphogenetic Protein 4

object_name: glioblastoma


subject: UMLS:C4331223

object_name: Childhood Glioblastoma


subject: UMLS:C4331223

object_name: adult glioblastoma


subject: GTOPDB:9297

subject_name: lutikizumab

object_name: psoriatic arthritis


subject: CHEMBL.COMPOUND:CHEMBL4594518

subject_name: LUTIKIZUMAB


subject: UMLS:C5226856


subject: UMLS:C1382107

subject_name: Suspension substance

object_name: Chronic small plaque psoriasis


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: eye disorder


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: pancreatic neoplasm


subject: UNII:I031V2H011

object_name: exocrine pancreatic carcinoma


subject: UNII:I031V2H011

object_name: malignant pancreatic neoplasm


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Emergencies


subject: CHEBI:7915

object_name: Encounter Admission Source - emergency


subject: CHEBI:63450

subject_name: Masitinib


subject: CHEBI:63450


subject: CHEBI:63450


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: hypoglycemia


subject: CHEBI:194186

object_name: Blood glucose below reference range (finding)


subject: CHEBI:194186

object_name: Hypoglycemia, CTCAE


subject: CHEBI:194186

object_name: prostate cancer


subject: CHEBI:194186

object_name: Diabetes


subject: CHEBI:52717

subject_name: Bortezomib

object_name: sickle cell-hemoglobin c disease syndrome


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Advanced Cholangiocarcinoma


subject: UMLS:C4744993


subject: CHEBI:90936

subject_name: Alectinib

object_name: Rare Neoplasm


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:132268

subject_name: Dacomitinib


subject: CHEBI:45783

subject_name: Imatinib


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Advanced breast cancer


subject: UMLS:C3827082


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: chronic hepatitis B virus infection


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:73493

subject_name: Glu-Glu-Glu

object_name: eastern equine encephalitis


subject: UNII:DY8NEE4XXW

subject_name: EEE


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: cleft palate


subject: CHEBI:51254

object_name: isolated cleft palate


subject: CHEBI:51254

object_name: cleft palate on exam


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: UMLS:C3489972

object_name: acute coronary syndrome


subject: UNII:5Q6TZN2HNM

subject_name: Ecallantide

object_name: Macular Edema


subject: UNII:5Q6TZN2HNM

object_name: central retinal vein occlusion


subject: UNII:0C1JUU9S0L

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Paroxysmal sympathetic hyperactivity


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: RXCUI:1656336

subject_name: sacubitril / valsartan Oral Product

object_name: peripheral vascular disease


subject: RXCUI:1656336

object_name: peripheral arterial disease


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: UNII:8GZG754X6M

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: CHEMBL.COMPOUND:CHEMBL2108512

subject_name: HEPATITIS B IMMUNE GLOBULIN


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Tinnitus


subject: CHEBI:74705

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:74705

object_name: Tinnitus, CTCAE 3.0


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UNII:3M7TX701A4

subject_name: SATOREOTIDE TRIZOXETAN

object_name: Childhood Breast Carcinoma


subject: UNII:3M7TX701A4

object_name: breast carcinoma


subject: UNII:3M7TX701A4

object_name: breast cancer


subject: DRUGBANK:DB17158

subject_name: Satoreotide trizoxetan


subject: DRUGBANK:DB17158


subject: DRUGBANK:DB17158


subject: CHEBI:23359

subject_name: colchicine

object_name: Arrhythmia


subject: UNII:1MTK0BPN8V

subject_name: Sotrovimab

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:1MTK0BPN8V

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:1MTK0BPN8V

object_name: Malignant Solid Neoplasm


subject: UMLS:C5432247


subject: UMLS:C5432247


subject: UMLS:C5432247


subject: CHEBI:15367

subject_name: Tretinoin

object_name: atrichia with papular lesions


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:93775

subject_name: Amethopterin

object_name: acute promyelocytic leukemia


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UMLS:C5706379

subject_name: Cytotoxic Agent-LAT1 Substrate QBS10072S

object_name: Childhood Astrocytoma


subject: UMLS:C5706379

object_name: glioma susceptibility 1


subject: UMLS:C5706379

object_name: astrocytic tumor


subject: UMLS:C5706379

object_name: astrocytoma


subject: UMLS:C5706379

object_name: pancreatic neoplasm


subject: UMLS:C5706379

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706379

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706379

object_name: Stomach cancer


subject: UMLS:C5706379

object_name: gastric cancer


subject: UMLS:C5706379

object_name: brain cancer


subject: UMLS:C5706379

object_name: brain neoplasm


subject: UMLS:C5706379

object_name: liver cancer


subject: UMLS:C5706379

object_name: liver neoplasm


subject: UMLS:C5706379

object_name: Adult Liver Carcinoma


subject: UMLS:C5706379

object_name: liver carcinoma


subject: UMLS:C5706379

object_name: renal carcinoma


subject: UMLS:C5706379

object_name: kidney neoplasm


subject: UMLS:C5706379

object_name: kidney cancer


subject: UMLS:C5706379

object_name: tongue cancer


subject: UMLS:C5706379

object_name: tongue carcinoma


subject: UMLS:C5706379

object_name: prostate carcinoma


subject: UMLS:C5706379

object_name: prostate cancer


subject: UMLS:C5706379

object_name: ovarian cancer


subject: UMLS:C5706379

object_name: ovarian neoplasm


subject: UMLS:C5706379

object_name: ovarian carcinoma


subject: UMLS:C5706379

object_name: bladder tumor


subject: UMLS:C5706379

object_name: urinary bladder carcinoma


subject: UMLS:C5706379

object_name: urinary bladder cancer


subject: UMLS:C5706379

object_name: childhood bladder carcinoma


subject: UMLS:C5706379

object_name: cervical cancer


subject: UMLS:C5706379

object_name: cervical carcinoma


subject: UMLS:C5706379

object_name: Neck Carcinoma


subject: UMLS:C5706379

object_name: head and neck neoplasm


subject: UMLS:C5706379

object_name: head and neck cancer


subject: UMLS:C5706379

object_name: esophageal cancer


subject: UMLS:C5706379

object_name: malignant urinary system neoplasm


subject: UMLS:C5706379

object_name: colorectal cancer


subject: UMLS:C5706379

object_name: colorectal carcinoma


subject: UMLS:C5706379

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5706379

object_name: type C thymoma


subject: UMLS:C5706379

object_name: pleural mesothelioma


subject: UMLS:C5706379

object_name: malignant pleural mesothelioma


subject: UMLS:C5706379

object_name: cholangiocarcinoma


subject: UMLS:C5706379

object_name: melanoma


subject: UMLS:C5706379

object_name: malignant soft tissue neoplasm


subject: UMLS:C5706379

object_name: sarcoma


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE

object_name: Hemorrhage


subject: GTOPDB:7055

subject_name: sucralfate


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: brain neoplasm


subject: UNII:42EK42WHI5

subject_name: Lorecivivint

object_name: Drug Interactions


subject: PR:000009882

subject_name: loricrin


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:74824

subject_name: Thr-Ala


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000016550


subject: PUBCHEM.COMPOUND:135449674

object_name: asthma


subject: PUBCHEM.COMPOUND:135449674

object_name: Bronchospasm


subject: PUBCHEM.COMPOUND:135449674

object_name: lung disorder


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: round cell sarcoma with EWSR1-non-ETS fusion


subject: UMLS:C4733491

subject_name: Chk1 Inhibitor LY2880070

object_name: Ewing sarcoma


subject: UMLS:C4733491


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: hemophagocytic syndrome


subject: PUBCHEM.COMPOUND:135565610

subject_name: hetrombopag

object_name: Drug action (disorder)


subject: UNII:9WGT51BDDL

subject_name: Hetrombopag


subject: UMLS:C1831790

subject_name: Algenpantucel-L

object_name: pancreatic neoplasm


subject: UMLS:C1831790

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1831790

object_name: malignant pancreatic neoplasm


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: CD19 Positive


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Philadelphia Chromosome Positive


subject: UNII:DPT0O3T46P


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:149504

object_name: pancreatic adenocarcinoma


subject: UMLS:C0004886

subject_name: BCG Vaccine

object_name: HER2 protein overexpression


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: superficial urinary bladder carcinoma


subject: GTOPDB:13716


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: Mitochondrial DNA deletion


subject: PUBCHEM.COMPOUND:135402009

object_name: Macrocytosis


subject: PUBCHEM.COMPOUND:135402009

object_name: Karyocytomegaly


subject: PUBCHEM.COMPOUND:135402009

object_name: Macrocytosis (finding)


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: UMLS:C4553183

subject_name: Androgen Receptor Inhibitor

object_name: triple-negative breast carcinoma


subject: UMLS:C4553183

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:39010

subject_name: MES


subject: CHEBI:39010


subject: CHEBI:39005

subject_name: schistosomin


subject: CHEBI:39005


subject: PR:000010676

subject_name: mesothelin


subject: PR:000010676


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: CHEBI:68481

subject_name: mTOR inhibitor


subject: CHEBI:68481


subject: UMLS:C2746052

subject_name: MTOR Inhibitors


subject: UMLS:C2746052


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Loss of Chromosome 5q


subject: UNII:GN465U8B72

subject_name: Nemolizumab

object_name: Chronic pruritus of unknown origin


subject: CHEBI:232540

object_name: anal squamous cell carcinoma


subject: CHEBI:232540

object_name: radiation exposure measurement


subject: UMLS:C4086591

subject_name: MnSOD Mimetic BMX-001


subject: UMLS:C4086591


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: UNII:SGW6W5758V

subject_name: Imrecoxib

object_name: ankylosing spondylitis


subject: UMLS:C0733521

subject_name: Ara-C

object_name: myeloproliferative neoplasm


subject: UMLS:C0733521

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C0733521

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate

object_name: long COVID-19


subject: PUBCHEM.COMPOUND:23431961

object_name: anosmia


subject: PUBCHEM.COMPOUND:23431961

object_name: Anosmia, CTCAE


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: circadian rhythm sleep disorder


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:76842

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:6121

subject_name: Ketamine

object_name: opioid abuse


subject: UMLS:C0040615

subject_name: Antipsychotic Agents

object_name: cardiac conduction defect


subject: UMLS:C0040615

object_name: antipsychotics and neuroleptics toxicity


subject: UMLS:C0040615

object_name: Arrhythmia


subject: UMLS:C5206750

subject_name: Eltivutabart

object_name: Childhood Solid Neoplasm


subject: UMLS:C5206750

object_name: Solid Neoplasm


subject: UMLS:C5206750

object_name: adult lymphoma


subject: UMLS:C5206750

object_name: lymphoma


subject: UMLS:C5206750

object_name: pediatric lymphoma


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: intermittent vascular claudication


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UNII:1CWH5SV4G2

subject_name: Dersimelagon

object_name: erythropoietic protoporphyria


subject: UNII:9CXQ3PF69U

subject_name: Imlunestrant

object_name: liver failure


subject: UNII:59WJ3TGA5K

subject_name: RILIMOGENE GALVACIREPVEC

object_name: prostate carcinoma


subject: UNII:59WJ3TGA5K

object_name: prostate cancer


subject: UNII:7PLH7RM47T

subject_name: RILIMOGENE GLAFOLIVEC


subject: UNII:7PLH7RM47T


subject: CHEBI:42645

subject_name: fluoro group


subject: CHEBI:42645


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Nausea, CTCAE_5


subject: PUBCHEM.COMPOUND:4715169

object_name: Nausea


subject: PUBCHEM.COMPOUND:4715169

object_name: Nausea, CTCAE_3


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:177770

subject_name: Ganetespib

object_name: colon carcinoma


subject: CHEBI:177770

object_name: colorectal cancer


subject: CHEBI:177770

object_name: colon cancer


subject: UMLS:C1115771

subject_name: Other medications

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C1115771


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Neck pain


subject: CHEBI:26710

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:26710

object_name: Neck Pain, CTCAE 3.0


subject: CHEBI:26710

object_name: Myofascial Trigger Point Pain


subject: CHEBI:26710

object_name: Myofacial Pain Syndromes


subject: CHEBI:26710

object_name: Cervicogenic Headache


subject: CHEBI:35341

subject_name: steroid


subject: CHEBI:35341


subject: CHEBI:35341


subject: CHEBI:35341


subject: CHEBI:35341


subject: CHEBI:35341


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: GTOPDB:4977

object_name: cryptosporidiosis


subject: UMLS:C0123759


subject: UMLS:C1328728


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: type 2 diabetes mellitus


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:232584

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:232584

object_name: acute myeloid leukemia


subject: CHEBI:232584

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:232584

object_name: chronic myelomonocytic leukemia


subject: CHEBI:232584

object_name: Myelodysplasia


subject: UMLS:C5418096

subject_name: DNMT1 Inhibitor NTX-301


subject: UMLS:C5418096


subject: UMLS:C5418096


subject: UMLS:C5418096


subject: UMLS:C5418096


subject: UMLS:C0338133

subject_name: Gemzar

object_name: peritoneum cancer


subject: UMLS:C0338133

object_name: ovarian cancer


subject: UMLS:C0338133

object_name: ovarian neoplasm


subject: UMLS:C0338133

object_name: ovarian carcinoma


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: High grade glioma


subject: CHEBI:77562

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:77562

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:75431

subject_name: ghrelin

object_name: Frailty Syndrome


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: UMLS:C0911014


subject: UMLS:C1327799

subject_name: Autologous Dendritic Cell-Adenovirus P53 Vaccine

object_name: renal carcinoma


subject: UMLS:C1327799

object_name: kidney neoplasm


subject: UMLS:C1327799

object_name: kidney cancer


subject: UMLS:C1327799

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1327799

object_name: skin melanoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: secondary adrenal insufficiency


subject: CHEBI:6413

subject_name: Letrozole

object_name: Endometrioma


subject: CHEBI:135207

subject_name: Clofedanol

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:2663

subject_name: Amiodarone

object_name: lung cancer


subject: CHEBI:2663

object_name: lung neoplasm


subject: CHEBI:2663

object_name: lung carcinoma


subject: UMLS:C5445109

subject_name: PCSK9 Inhibitors

object_name: aortic valve disease 1


subject: UMLS:C5445109

object_name: aortic valve calcification


subject: UNII:BIW199E18V

subject_name: Relamorelin

object_name: Complications of Diabetes Mellitus


subject: UMLS:C4045486

subject_name: relamorelin


subject: CHEBI:84500

subject_name: varenicline

object_name: Atypical behavior


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Surgical procedure, unspecified


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: colon adenocarcinoma


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: congestive heart failure


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632

object_name: HIV infection


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Gaucher disease type I


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Chronic lymphocytic leukaemia stage 2


subject: UNII:1C6V77QF41

object_name: Chronic lymphocytic leukaemia stage 1


subject: UNII:1C6V77QF41

object_name: Chronic lymphocytic leukaemia stage 0


subject: UNII:1C6V77QF41

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:44915

subject_name: Propofol

object_name: Allergy


subject: CHEBI:44915

object_name: hypersensitivity reaction disease


subject: CHEBI:44915

object_name: Emotional hypersensitivity


subject: CHEBI:44915

object_name: Soy allergy


subject: CHEBI:44915

object_name: Egg allergy


subject: CHEBI:90284

subject_name: pirazofurin

object_name: ptosis


subject: CHEBI:90284

object_name: Synkinesis


subject: CHEBI:90284

object_name: Hyperactivity


subject: CHEBI:90284

object_name: Hyperkinesia


subject: CHEBI:90284

object_name: Facial Paresis


subject: CHEBI:90284

object_name: Bell's palsy


subject: CHEBI:74795

subject_name: Pro-Phe


subject: CHEBI:74795


subject: CHEBI:74795


subject: CHEBI:74795


subject: CHEBI:74795


subject: CHEBI:74795


subject: CHEBI:59527

object_name: colorectal cancer


subject: CHEBI:59527

object_name: colorectal carcinoma


subject: CHEBI:59527

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:15407

subject_name: Ephedrine

object_name: postpartum hemorrhage


subject: CHEBI:15407

object_name: Post-partum hemorrhage


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:33569


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: UMLS:C2919980

subject_name: passiflora incarnata flowering top extract

object_name: Impacted third molar tooth


subject: UMLS:C2919980

object_name: dental phobia


subject: UMLS:C4059137

subject_name: Passiflora incarnata whole extract


subject: UMLS:C4059137


subject: UMLS:C3495130

subject_name: Passiflora incarnata homeopathic preparation


subject: UMLS:C3495130


subject: CHEBI:6931

subject_name: Midazolam


subject: UNII:OGN7X90BT8

subject_name: Lenabasum

object_name: EXCESS LMW-DNA


subject: UNII:OGN7X90BT8

object_name: lupus vulgaris


subject: UNII:OGN7X90BT8

object_name: lupus erythematosus


subject: UNII:OGN7X90BT8

object_name: discoid lupus erythematosus


subject: UNII:OGN7X90BT8

object_name: st. Louis encephalitis


subject: UMLS:C5854073


subject: UMLS:C5854073


subject: UMLS:C5854073


subject: UMLS:C5854073


subject: UMLS:C5854073


subject: CHEBI:50249

subject_name: anticoagulant

object_name: atrial septal defect, ostium secundum type


subject: CHEBI:50249

object_name: patent foramen ovale


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]


subject: UMLS:C3536711


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Encounter due to multiparity


subject: PUBCHEM.COMPOUND:53477758

object_name: Multiparity


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: malignant neoplasm of bladder stage I


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Carcinoma of Bladder


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Effects of chemotherapy


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: cancer


subject: CHEBI:184693

object_name: neoplasm


subject: CHEBI:87631

subject_name: statin

object_name: coronary microvascular disorder


subject: UMLS:C3536932

subject_name: HMG-CoA Reductase Inhibitor [EPC]


subject: UMLS:C1882164

subject_name: Oral Sodium Phenylbutyrate

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:50662

subject_name: Marimastat

object_name: congenital vascular malformation


subject: CHEBI:50662

object_name: vascular malformation


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: CHEBI:31355

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:31355

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:31355

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:8884

subject_name: Rocuronium

object_name: lumbar spinal stenosis


subject: CHEBI:27732

subject_name: Caffeine

object_name: premature birth (history)


subject: CHEBI:149520

subject_name: Polihexanide

object_name: staphylococcus aureus infection


subject: CHEBI:149520

object_name: Asymptomatic Colonization


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: punctate palmoplantar keratoderma type III


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70752

subject_name: Dabigatran


subject: PR:000014345

object_name: Periodontal Pocket


subject: PR:000000314

subject_name: zinc finger FYVE domain-containing protein 9 isoform 2


subject: PR:000000315

subject_name: zinc finger FYVE domain-containing protein 9 isoform 3


subject: PR:000000125

subject_name: zinc finger FYVE domain-containing protein 9


subject: PR:000014348


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Osteochondritis


subject: CHEBI:36791


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: UMLS:C5555948

subject_name: Imzokitug

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5555948

object_name: triple-negative breast carcinoma


subject: UMLS:C5555948

object_name: pancreatic adenocarcinoma


subject: UMLS:C5555948

object_name: urothelial carcinoma


subject: UMLS:C5555948

object_name: transitional cell carcinoma


subject: UMLS:C5555948

object_name: renal cell carcinoma


subject: UMLS:C5555948

object_name: cervical cancer


subject: UMLS:C5555948

object_name: cervical carcinoma


subject: UMLS:C5555948

object_name: ovarian cancer


subject: UMLS:C5555948

object_name: ovarian neoplasm


subject: UMLS:C5555948

object_name: melanoma


subject: UMLS:C1710687

object_name: Plexosarcoma


subject: UMLS:C1710687

object_name: digestive system neoplasm


subject: UMLS:C1710687

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C3661049

object_name: Heartburn


subject: UMLS:C3661049

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:10033

subject_name: Warfarin

object_name: epilepsy


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: fetal alcohol spectrum disorder


subject: CHEBI:4469

object_name: fetal alcohol syndrome


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE


subject: UNII:4B3SC438HI


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6887


subject: UMLS:C0600472

subject_name: Long Interspersed Nucleotide Element-1

object_name: Small cell lung cancer extensive stage


subject: UniProtKB:P03101

subject_name: VL1_HPV16 Major capsid protein L1 (sprot)


subject: UniProtKB:Q07860

subject_name: VL1_HPV04 Major capsid protein L1 (sprot)


subject: PR:000029475

subject_name: CYFIP-related Rac1 interactor B


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: MESH:D012900

subject_name: Smallpox Vaccine

object_name: Vaccinia virus infection


subject: MESH:D012900

object_name: monkeypox


subject: MESH:D012900

object_name: cowpox


subject: CHEMBL.COMPOUND:CHEMBL2108688

subject_name: SMALLPOX VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2108688


subject: CHEMBL.COMPOUND:CHEMBL2108688


subject: UMLS:C2700141

subject_name: vaccinia virus strain New York City Board of Health live antigen


subject: UMLS:C2700141


subject: UMLS:C2700141


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Postoperative Pain, Chronic


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UMLS:C2987456

subject_name: NA17.A2 Peptide Vaccine

object_name: Melanoma recurrent


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Acne inversa


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C1696294

subject_name: Yaz


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: malaria


subject: CHEBI:139554

object_name: Recurrent lower respiratory tract infections


subject: PR:000034030

subject_name: FMN reductase (NADH) RutF

object_name: diarrhea


subject: PR:000034030


subject: CHEBI:166679

subject_name: Retapamulin

object_name: bacterial infectious disease


subject: UNII:4MG6O8991R


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: alcoholic hepatitis


subject: UMLS:C5779650


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C3827082


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: PUBCHEM.COMPOUND:139350422

object_name: cancer


subject: UMLS:C5205927


subject: UMLS:C5205927

object_name: renal cell adenocarcinoma


subject: UMLS:C5205927

object_name: renal cell carcinoma


subject: UMLS:C5205927


subject: UMLS:C3851199

object_name: type 2 diabetes mellitus


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: vascular inflammations


subject: UNII:FYS6T7F842

object_name: coronary artery disorder


subject: UNII:FYS6T7F842

object_name: coronary atherosclerosis


subject: CHEBI:3723

subject_name: Citalopram

object_name: Alzheimer disease type 1


subject: CHEBI:9144

subject_name: Silibinin

object_name: Melasma


subject: CHEBI:125451

subject_name: silymarin


subject: UNII:B96UX1DDKS

subject_name: Gemcabene

object_name: metabolic dysfunction-associated steatotic liver disease


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: pseudotumor cerebri


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:73611

subject_name: Met-Gly

object_name: X-linked Alport syndrome


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: posterior urethral valve


subject: DRUGBANK:DB19340

subject_name: Tabirafusp tedromer

object_name: Wet age-related macular degeneration


subject: UNII:7HW5CX6OD5

subject_name: TARCOCIMAB TEDROMER


subject: UMLS:C5707841

subject_name: Tarcocimab tedromer


subject: PUBCHEM.COMPOUND:155487963

subject_name: UK

object_name: long COVID-19


subject: PR:000023663

subject_name: uridylate kinase


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Metastatic Breast Carcinoma in the Brain


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:67272

subject_name: Perifosine

object_name: malignant glioma


subject: CHEBI:67272

object_name: brain cancer


subject: CHEBI:67272

object_name: brain neoplasm


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: Friedreich ataxia


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UMLS:C5784989

subject_name: HER2 Inhibitor ELVN-002

object_name: HER2 mutant non-small cell lung cancer


subject: UMLS:C5784989

object_name: ERBB2 Gene Mutation


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: HER2 gene amplification


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UNII:H7W2XU652Q

subject_name: DECORIN

object_name: OPTN-related open angle glaucoma


subject: CHEBI:63660

object_name: Ischemic stroke


subject: CHEBI:63618

subject_name: Pravastatin


subject: UMLS:C1831768

subject_name: Transdermal Estrogen

object_name: Menopause present (finding)


subject: UMLS:C1831768

object_name: Menopause


subject: UMLS:C1831768

object_name: Rotator cuff tear


subject: UMLS:C1831768

object_name: Rotator Cuff Injuries


subject: UMLS:C1831768

object_name: rotator cuff syndrome


subject: UMLS:C1831768

object_name: Menopause related conditions


subject: CHEBI:134500

object_name: outcomes general quality of life


subject: CHEBI:134500

object_name: Perceived quality of life


subject: CHEBI:134500

object_name: Good quality of life


subject: CHEBI:94563

subject_name: Benzydamine


subject: CHEBI:94563


subject: CHEBI:94563


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:42446

subject_name: Esflurbiprofen


subject: CHEBI:42446


subject: CHEBI:42446


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:5130


subject: CHEBI:5130


subject: CHEBI:4875

subject_name: Etanercept

object_name: esophageal adenocarcinoma


subject: CHEBI:4875

object_name: lung adenocarcinoma


subject: CHEBI:4875

object_name: cervical adenocarcinoma


subject: CHEBI:4875

object_name: adenocarcinoma


subject: CHEBI:4875

object_name: bile duct adenocarcinoma


subject: CHEBI:4875

object_name: gastric adenocarcinoma


subject: CHEBI:4875

object_name: pancreatic neoplasm


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: UMLS:C0142340

subject_name: Sinemet CR

object_name: diabetic retinopathy


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: temporomandibular joint disorder


subject: CHEBI:52763


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:91529


subject: PUBCHEM.COMPOUND:287691

subject_name: Thiocolchicoside


subject: GTOPDB:7684

subject_name: lebrikizumab

object_name: allergic asthma


subject: CHEMBL.COMPOUND:CHEMBL1743035

subject_name: LEBRIKIZUMAB


subject: UMLS:C1881890


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: respiratory tract infectious disorder


subject: CHEBI:32599

object_name: Arrhythmia


subject: UMLS:C4331834

subject_name: Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4331834

object_name: Embolism, Tumor


subject: UMLS:C4331834

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:121427236

subject_name: YIMITASVIR

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:121427236

object_name: chronic hepatitis C virus infection


subject: UNII:K465JAH79P


subject: UNII:K465JAH79P


subject: CHEBI:88316

subject_name: Nefopam

object_name: Mechanical ventilation finding


subject: CHEBI:88316

object_name: Critical Illness


subject: CHEBI:88316

object_name: pain agnosia


subject: CHEBI:88316

object_name: Pain insensitivity


subject: CHEBI:88316

object_name: Sedation


subject: CHEBI:88316

object_name: Sedated


subject: UMLS:C3864383

subject_name: Lumason

object_name: breast fibrocystic change, proliferative type


subject: CHEBI:75929

object_name: silent stroke


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: Physical trauma


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: Injury


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: Trauma


subject: UMLS:C0593103

subject_name: Novoseven


subject: UMLS:C0593103


subject: UMLS:C0593103


subject: PR:000007301

subject_name: coagulation factor VII


subject: PR:000007301


subject: PR:000007301


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C0796320

subject_name: Hepatitis B Antigen Vaccine

object_name: hepatitis B


subject: UMLS:C0019168

subject_name: Hepatitis B Surface Antigens


subject: CHEBI:119915

subject_name: Fentanyl

object_name: respiration; insufficient or poor, newborn


subject: CHEBI:119915

object_name: Infant, Premature, Diseases


subject: UNII:8F63U28T2V

subject_name: Imexon

object_name: Neoplasm Metastasis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Hodgkin's lymphoma, lymphocytic-histiocytic predominance


subject: CHEBI:31355

object_name: Adult Lymphocyte-Rich Classical Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Hodgkin's disease lymphocyte depletion type refractory


subject: CHEBI:31355

object_name: Hodgkin's disease lymphocyte depletion type recurrent


subject: CHEBI:31355

object_name: Hodgkin's disease mixed cellularity refractory


subject: CHEBI:31355

object_name: Hodgkin's disease nodular sclerosis refractory


subject: CHEBI:31355

object_name: Hodgkin's disease mixed cellularity recurrent


subject: CHEBI:31355

object_name: Hodgkin's disease nodular sclerosis recurrent


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:126714060

object_name: psoriasis vulgaris


subject: MESH:C505143

subject_name: Boostrix

object_name: Pertussis/whooping cough


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Postoperative delirium


subject: UMLS:C0360094

object_name: Fused vertebrae


subject: UMLS:C5783010

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5783010

object_name: acute myeloid leukemia


subject: UMLS:C5783010

object_name: Myelodysplasia


subject: UNII:ZLW14X2D30

object_name: sickle cell disease


subject: UNII:ZLW14X2D30

object_name: Diamond-Blackfan anemia


subject: UNII:ZLW14X2D30

object_name: Aase syndrome


subject: UNII:ZLW14X2D30

object_name: Cooley's anemia


subject: UMLS:C0108779

subject_name: CD3 Antigens


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: MAP2K2 Gene Mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: MAP2K1 Gene Mutation


subject: UMLS:C4287812

subject_name: ulixertinib


subject: UMLS:C4287812


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: hormone deficiency


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Cervical myelopathy


subject: CHEBI:9927

subject_name: Valsartan

object_name: sarcopenia


subject: UNII:MT6QI8324A

subject_name: Magnesium lactate

object_name: Muscle spasm


subject: UNII:MT6QI8324A

object_name: Muscle Cramp, CTCAE


subject: CHEBI:50249

subject_name: anticoagulant

object_name: female reproductive organ cancer


subject: CHEBI:50249

object_name: Cancer-associated thrombosis


subject: CHEBI:50249

object_name: vaginal cancer


subject: CHEBI:50249

object_name: vaginal carcinoma


subject: CHEBI:50249

object_name: endometrial cancer


subject: CHEBI:50249

object_name: uterine corpus cancer


subject: CHEBI:50249

object_name: endometrial carcinoma


subject: CHEBI:50249

object_name: cervical cancer


subject: CHEBI:50249

object_name: cervical carcinoma


subject: CHEBI:50249

object_name: ovarian cancer


subject: CHEBI:50249

object_name: ovarian neoplasm


subject: CHEBI:50249

object_name: ovarian carcinoma


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]

object_name: venous thromboembolism


subject: UMLS:C3536711

object_name: thrombophilia due to thrombin defect


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: rheumatoid arthritis


subject: CHEBI:47426

subject_name: Furosemide

object_name: Maternal hypertension


subject: CHEBI:47426

object_name: pregnancy disorder


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: transient ischemic attack


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: ureter cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Metabolic associated fatty liver disease


subject: UMLS:C2001395

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C2001395

object_name: amyotrophic lateral sclerosis


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:231683

subject_name: Anakinra

object_name: idiopathic recurrent pericarditis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:78351

subject_name: amantadine sulfate

object_name: Postoperative cognitive dysfunction


subject: UNII:A9ZZD585U6

subject_name: Diammonium Glycyrrhizinate

object_name: chronic hepatitis B virus infection


subject: UNII:A9ZZD585U6

object_name: hepatitis B


subject: UNII:A9ZZD585U6

object_name: hepatitis


subject: PUBCHEM.COMPOUND:3495

subject_name: Glycyrrhizin


subject: PUBCHEM.COMPOUND:3495


subject: PUBCHEM.COMPOUND:3495


subject: CHEMBL.COMPOUND:CHEMBL4297742

subject_name: DIAMMONIUM GLYCYRRHIZINATE


subject: CHEMBL.COMPOUND:CHEMBL4297742


subject: CHEMBL.COMPOUND:CHEMBL4297742


subject: CHEBI:233492

subject_name: Magnesium Isoglycyrrhizinate


subject: CHEBI:233492


subject: CHEBI:233492


subject: UMLS:C1958566

subject_name: magnesium isoglycyrrhizinate


subject: UMLS:C1958566


subject: UMLS:C1958566


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Bone fracture


subject: PUBCHEM.COMPOUND:521372

object_name: Fracture, CTCAE


subject: CHEBI:187893

subject_name: Baclofen

object_name: pain agnosia


subject: CHEBI:187893

object_name: Pain insensitivity


subject: CHEBI:187893

object_name: Acute Pain


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: localized scleroderma


subject: CHEBI:50749

object_name: Morphea


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: human papilloma virus infection


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Neck Carcinoma


subject: CHEBI:51254

object_name: head and neck neoplasm


subject: CHEBI:51254

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: UMLS:C1831849

object_name: Solid Neoplasm


subject: UMLS:C1831849

object_name: neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: acute myeloid leukemia


subject: UMLS:C3641122


subject: CHEBI:63631

subject_name: Topiramate

object_name: drug-induced dyskinesia


subject: PUBCHEM.COMPOUND:24748496

subject_name: Allisartan isoproxil

object_name: Blood Pressure Finding


subject: PUBCHEM.COMPOUND:24748496

object_name: Systemic arterial pressure


subject: PUBCHEM.COMPOUND:24748496

object_name: Prehypertension


subject: PUBCHEM.COMPOUND:24748496

object_name: adverse effect


subject: PUBCHEM.COMPOUND:24748496

object_name: Heart Disease Risk Factors


subject: PUBCHEM.COMPOUND:24748496

object_name: type 2 diabetes mellitus


subject: UNII:DI4662MK4N

subject_name: ALLISARTAN ISOPROXIL


subject: UNII:DI4662MK4N


subject: UNII:DI4662MK4N


subject: UNII:DI4662MK4N


subject: UNII:DI4662MK4N


subject: UNII:DI4662MK4N


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: Dravet syndrome


subject: PUBCHEM.COMPOUND:131751561

object_name: developmental and epileptic encephalopathy, 6A


subject: PUBCHEM.COMPOUND:131751561

object_name: Partial Seizure


subject: PUBCHEM.COMPOUND:131751561

object_name: Lennox-Gastaut syndrome


subject: PUBCHEM.COMPOUND:131751561

object_name: tuberous sclerosis


subject: PUBCHEM.COMPOUND:131751561

object_name: situs inversus


subject: PUBCHEM.COMPOUND:131751561

object_name: epilepsy


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:94633

subject_name: Tetradecylthioacetic acid

object_name: inherited lipid metabolism disorder


subject: CHEBI:94633

object_name: Dyslipidemia


subject: CHEBI:94633


subject: CHEBI:44915

subject_name: Propofol

object_name: Inappropriate device stimulation of tissue


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802

object_name: c.delivery; previous surgery, gynecological


subject: CHEBI:9939

subject_name: Vecuronium


subject: CHEBI:9939